HMinusDZone Tuesday, 12/31/19 06:08:14 PM Re: None Post # of 1377 $CTST is a risky buy, but a buy nonetheless (if you're willing to wait it out in Q1/Q2 2020). This is one of only 4 pot stocks with wholesale agreements. They have a well-established operation and Health Canada is reportedly working with the firm to ensure compliance is met (https://www.stcatharinesstandard.ca/news-story/9787747-can-t-grow-or-sell-pot-small-staff-remains-at-canntrust-s-pelham-site/). Forget all the other hooplah, "chart analytics", etc. This isn't penny stock DD. This is understanding the industry, the regulatory body, and whether the company's leadership has the ability to keep it compliant and earn its licensing back. Everything rests on Q1 2020 projection of that compliance being met. Personally, I don't care if the company falls off NYSE. It'll hit OTC and trade as a penny stock. We may have to deal with more of the loud, annoying, utterly uninformed dump-n-dumpers. Oh well. I will be buying on risk, knowing I can lose it all. But I believe it'll recover, and everyone knows 2020 is going to be a steamroller for pot stocks.